Live Nation Entertainment

▲ Bull Case

• ◆Legal discount resolved: State AGs accept DOJ behavioral framework → full no-antitrust intrinsic of $220-260/share unlocked; stock re-rates +30-54% from $169 over 12-18 months.
• ◆FCF inflection drives re-rating: Venue Nation capex normalizes on schedule; FY2027 FCF ~$1.2B drives institutional re-ownership as the stock transitions from an AOI story to a FCF story; 20x EV/AOI multiple justified.
• ◆International expansion multiplies the flywheel: International attendance at >50% and growing adds new sponsor markets, new Ticketmaster GTV, and new Venue Nation opportunities in Europe and Asia-Pacific — extending the 10%/yr AOI growth runway through FY2030.

▼ Bear Case

• ◆Ticketmaster divestiture ordered (10% probability): Full structural separation of Ticketmaster (-47% of AOI) → stock falls to $60-80; integrated flywheel destroyed; no re-rating catalyst.
• ◆Venue Nation capex overrun/delay: Taper doesn't materialize until FY2029; FCF remains suppressed; stock stays range-bound at $140-160; no re-rating without FCF confirmation.
• ◆Fee cap legislation surprises: Federal legislation caps ticketing fees at 10% of face value; Ticketmaster AOI shrinks 40-50%; even without divestiture, integrated value falls to ~$120-140.

“The central debate is '33% divestiture probability (market-implied) vs. 15-20% (analyst consensus).' The market is pricing in 33% probability of Ticketmaster divestiture based on the antitrust liability finding (April 2026) and state AG filings. Sell-side analysts who cover antitrust situations tend to assign 15-20% probability, citing the DOJ behavioral settlement as a strong precedent against structural remedies. The key question is whether state AG remedy phase follows the federal DOJ consent decree or whether state courts impose independent structural remedies. The bull case argues federal behavioral settlements historically constrain state AG ambition; the bear case notes that New York and California have historically diverged from federal antitrust settlements in high-profile cases. A secondary debate concerns FCF inflection credibility: skeptics argue Venue Nation capex will not taper as quickly as management suggests given 20+ simultaneous construction projects, while bulls point to the deferred revenue record ($6.6B, +22% YoY) as evidence that demand justifies the investment.”

• ◆State AG remedy phase ruling (Q3-Q4 2026): +$50/share if behavioral-only outcome; -$90/share if divestiture ordered
• ◆Q2 2026 earnings (August 2026): FCF vs. Venue Nation capex schedule confirms or challenges taper story
• ◆Federal court ruling on structural remedies (Q4 2026-Q1 2027): independent from state AGs; could impose structural remedies
• ◆FY2027 FCF confirmation (~$1.2B expected, February 2027): re-rating catalyst if FCF inflection confirmed; triggers institutional re-ownership
• ◆International expansion metrics (quarterly): >50% attendance share and growing validates TAM expansion thesis

• ◆Ticketmaster structural divestiture ordered (10% probability): -53% to -64% stock impact
• ◆Venue Nation capex taper delayed 12+ months (25% probability): -10% to -15% stock impact
• ◆Federal fee cap legislation passes (15% probability): -25% to -35% within integrated LYV
• ◆US recession suppresses discretionary spending (20% probability): -15% to -25% attendance/per-fan; -$25-40/share
• ◆SBC dilution erodes per-share value (certain): -3%/yr EPS drag permanently
• ◆State AG remedy delays capital allocation/Venue Nation investment (30% probability): reduces FCF normalization confidence